886560

Biogen, Inc. — FEI 1220951

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 3, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
1001921 CFR 314.80(c)(1)(iii)Non-applicant reports directly to FDA
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report